Functional analyses of polymorphic variants of human terminal deoxynucleotidyl transferase

Genes and Immunity

Volumn 16, Issue 6, 2015, Pages 388-398

  Troshchynsky, A ^a   Dzneladze, I ^a,c   Chen, L ^a   Sheng, Y ^a   Saridakis, V ^a   Wu, G E ^a,b  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; LYMPHOCYTE ANTIGEN RECEPTOR; IMMUNOGLOBULIN VARIABLE REGION; NUCLEOTIDE;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EMBRYO; GENETIC RECOMBINATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; POLYMERIZATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; VDJ RECOMBINATION; ADAPTIVE IMMUNITY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; JURKAT CELL LINE; METABOLISM;

ADAPTIVE IMMUNITY; DNA NUCLEOTIDYLEXOTRANSFERASE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; JURKAT CELLS; MODELS, MOLECULAR; NUCLEOTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANTIGEN, T-CELL; V(D)J RECOMBINATION;

EID: 84941026025     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.19     Document Type: Article

References (51)

1. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014; 506: 376-381
2. Mabert K, Cojoc M, Peitzsch C, Kurth I, Souchelnytskyi S, Dubrovska A. Cancer biomarker discovery: current status and future perspectives. Int J Radiat Biol 2014; 90: 659-677
3. Danchin E, Vitiello V, Vienne A, Richard O, Gouret P, McDermott MF et al. The major histocompatibility complex origin. Immunol Rev 2004; 198: 216-232
4. Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet 2013; 14: 301-323
5. Gozalbo-Lopez B, Andrade P, Terrados G, De Andres B, Serrano N, Cortegano I et al. A role for DNA polymerase mu in the emerging DJH rearrangements of the postgastrulation mouse embryo. Mol Cell Biol 2009; 29: 1266-1275
6. Lewis SM, Wu GE. The origins of V(D)J recombination. Cell 1997; 88: 159-162
7. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv Immunol 1994; 56: 27-150
8. Repasky JA, Corbett E, Boboila C, Schatz DG. Mutational analysis of terminal deoxynucleotidyltransferase-mediated N-nucleotide addition in V(D)J recombination. J Immunol 2004; 172: 5478-5488
9. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 2002; 71: 101-132
10. Schatz DG, Spanopoulou E. Biochemistry of V(D)J recombination. Curr Top Microbiol Immunol 2005; 290: 49-85
11. Lewis SM, Wu GE. The old and the restless. J Exp Med 2000; 191: 1631-1636
12. Swanson PC. A RAG-1/RAG-2 tetramer supports 12/23-regulated synapsis, cleavage, and transposition of V(D)J recombination signals. Mol Cell Biol 2002; 22: 7790-7801
13. Grundy GJ, Ramon-Maiques S, Dimitriadis EK, Kotova S, Biertumpfel C, Heymann JB et al. Initial stages of V(D)J recombination: the organization of RAG1/2 and RSS DNA in the postcleavage complex. Mol Cell 2009; 35: 217-227
14. Fowler JD, Suo Z. Biochemical, structural, and physiological characterization of terminal deoxynucleotidyl transferase. Chem Rev 2006; 106: 2092-2110
15. Komori T, Okada A, Stewart V, Alt FW. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 1993; 261: 1171-1175
16. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 1993; 261: 1175-1178
17. Boubakour-Azzouz I, Bertrand P, Claes A, Lopez BS, Rougeon F. Terminal deoxynucleotidyl transferase requires KU80 and XRCC4 to promote N-Addition at non- V(D)J chromosomal breaks in non-lymphoid cells. Nucleic Acids Res 2012; 40: 8381-8391
18. Benedict CL, Gilfillan S, Thai TH, Kearney JF. Terminal deoxynucleotidyl transferase and repertoire development. Immunol Rev 2000; 175: 150-157
19. Motea EA, Berdis AJ. Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase. Biochimica et Biophysica Acta 2010; 1804: 1151-1166
20. Delarue M, Boule JB, Lescar J, Expert-Bezancon N, Jourdan N, Sukumar N et al. Crystal structures of a template-independent DNA polymerase: murine terminal deoxynucleotidyltransferase. EMBO J 2002; 21: 427-439
21. Fetter M, Zee DS, Koenig E, Dichgans J. Head-shaking nystagmus during vestibular compensation in humans and rhesus monkeys. Acta Oto-laryngologica 1990; 110: 175-181
22. Gouge J, Rosario S, Romain F, Beguin P, Delarue M. Structures of intermediates along the catalytic cycle of terminal deoxynucleotidyltransferase: dynamical aspects of the two-metal ion mechanism. J Mol Biol 2013; 425: 4334-4352
23. Yamtich J, Sweasy JB. DNA polymerase family X: function, structure, and cellular roles. Biochimica et Biophysica acta 2010; 1804: 1136-1150
24. Thai TH, Purugganan MM, Roth DB, Kearney JF. Distinct and opposite diversifying activities of terminal transferase splice variants. Nat Immunol 2002; 3: 457-462
25. Thai TH, Kearney JF. Isoforms of terminal deoxynucleotidyltransferase: developmental aspects and function. Adv Immunol 2005; 86: 113-136
26. Thai TH, Kearney JF. Distinct and opposite activities of human terminal deoxynucleotidyltransferase splice variants. J Immunol 2004; 173: 4009-4019
27. Di Santo R, Maga G. Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy. Curr Med Chem 2006; 13: 2353-2368
28. Locatelli GA, Di Santo R, Crespan E, Costi R, Roux A, Hubscher U et al. Diketo hexenoic acid derivatives are novel selective non-nucleoside inhibitors of mammalian terminal deoxynucleotidyl transferases, with potent cytotoxic effect against leukemic cells. Mol Pharmacol 2005; 68: 538-550
29. Kodama EN, McCaffrey RP, Yusa K, Mitsuya H. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells. Biochem Pharmacol 2000; 59: 273-281
30. Conde C, Weller S, Gilfillan S, Marcellin L, Martin T, Pasquali JL. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice. J Immunol 1998; 161: 7023-7030
31. Feeney AJ, Lawson BR, Kono DH, Theofilopoulos AN. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice. J Immunol 2001; 167: 3486-3493
32. Marshall AJ, Doyen N, Bentolila LA, Paige CJ, Wu GE. Terminal deoxynucleotidyl transferase expression during neonatal life alters D(H) reading frame usage and Ig-receptor-dependent selection of V regions. J Immunol 1998; 161: 6657-6663
33. Gavin MA, Bevan MJ. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 1995; 3: 793-800
34. Schelonka RL, Ivanov II, Vale AM, Szymanska E, Zemlin M, Gartland GL et al. The CDR-H3 repertoire from TdT-deficient adult bone marrow is a close, but not exact, homologue of the CDR-H3 repertoire from perinatal liver. J Immunol 2010; 185: 6075-6084
35. Robey IF, Peterson M, Horwitz MS, Kono DH, Stratmann T, Theofilopoulos AN et al. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice. J Immunol 2004; 172: 4624-4629
36. Hesse JE, Lieber MR, Gellert M, Mizuuchi K. Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals. Cell 1987; 49: 775-783
37. Lieber MR, Hesse JE, Mizuuchi K, Gellert M. Studies of V(D)J recombination with extrachromosomal substrates. Curr Top Microbiol Immunol 1988; 137: 94-99
38. Lieber MR, Hesse JE, Mizuuchi K, Gellert M. Developmental stage specificity of the lymphoid V(D)J recombination activity. Genes Dev 1987; 1: 751-761
39. Raghavan SC, Hsieh CL, Lieber MR. Both V(D)J coding ends but neither signal end can recombine at the bcl-2 major breakpoint region, and the rejoining is ligase IV dependent. Mol Cell Biol 2005; 25: 6475-6484
40. Gauss GH, Lieber MR. Mechanistic constraints on diversity in human V(D)J recombination. Mol Cell Biol 1996; 16: 258-269
41. Bertocci B, De Smet A, Weill JC, Reynaud CA. Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity 2006; 25: 31-41
42. Liu Q, Chen H, Ojode T, Gao X, Anaya-O'Brien S, Turner NA et al. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood 2012; 120: 181-189
43. Allison AC. Genetic control of resistance to human malaria. Curr Opin Immunol 2009; 21: 499-505
44. Romain F, Barbosa I, Gouge J, Rougeon F, Delarue M. Conferring a templatedependent polymerase activity to terminal deoxynucleotidyltransferase by mutations in the Loop1 region. Nucleic Acids Res 2009; 37: 4642-4656
45. Purugganan MM, Shah S, Kearney JF, Roth DB. Ku80 is required for addition of N nucleotides to V(D)J recombination junctions by terminal deoxynucleotidyl transferase. Nucleic Acids Res 2001; 29: 1638-1646
46. Nick McElhinny SA, Havener JM, Garcia-Diaz M, Juarez R, Bebenek K, Kee BL et al. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol Cell 2005; 19: 357-366
47. Molano ID, Redmond S, Sekine H, Zhang XK, Reilly C, Hutchison F et al. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clin Immunol 2003; 107: 186-197
48. Gauss GH, Lieber MR. Unequal signal and coding joint formation in human V(D)J recombination. Mol Cell Biol 1993; 13: 3900-3906
49. Spanopoulou E, Cortes P, Shih C, Huang CM, Silver DP, Svec P et al. Localization, interaction, and RNA binding properties of the V(D)J recombination-Activating proteins RAG1 and RAG2. Immunity 1995; 3: 715-726
50. Yuan SW, Agard EA, Larijani M, Wu GE. Coding joint diversity in mature and immature B-cell lines. Scand J Immunol 2005; 62: 114-118
51. Menetski JP, Gellert M. V(D)J recombination activity in lymphoid cell lines is increased by agents that elevate cAMP. Proc Natl Acad Sci USA 1990; 87: 9324-9328